Logo image of YJ

YUNJI INC-ADR (YJ) Stock Fundamental Analysis

NASDAQ:YJ - Nasdaq - US98873N3052 - ADR - Currency: USD

1.603  +0.01 (+0.82%)

Fundamental Rating

2

Taking everything into account, YJ scores 2 out of 10 in our fundamental rating. YJ was compared to 31 industry peers in the Broadline Retail industry. YJ has a great financial health rating, but its profitability evaluates not so good. YJ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

YJ had negative earnings in the past year.
YJ had a negative operating cash flow in the past year.
In the past 5 years YJ reported 4 times negative net income.
YJ had a negative operating cash flow in each of the past 5 years.
YJ Yearly Net Income VS EBIT VS OCF VS FCFYJ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B

1.2 Ratios

YJ has a worse Return On Assets (-9.11%) than 70.97% of its industry peers.
Looking at the Return On Equity, with a value of -11.43%, YJ is doing worse than 61.29% of the companies in the same industry.
Industry RankSector Rank
ROA -9.11%
ROE -11.43%
ROIC N/A
ROA(3y)-9%
ROA(5y)-5.42%
ROE(3y)-11.82%
ROE(5y)-7.53%
ROIC(3y)N/A
ROIC(5y)N/A
YJ Yearly ROA, ROE, ROICYJ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K -80K

1.3 Margins

YJ has a Gross Margin of 31.10%. This is in the lower half of the industry: YJ underperforms 77.42% of its industry peers.
YJ's Gross Margin has improved in the last couple of years.
YJ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.45%
GM growth 5Y20.21%
YJ Yearly Profit, Operating, Gross MarginsYJ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

7

2. Health

2.1 Basic Checks

YJ does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, YJ has less shares outstanding
Compared to 5 years ago, YJ has less shares outstanding
YJ has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
YJ Yearly Shares OutstandingYJ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
YJ Yearly Total Debt VS Total AssetsYJ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

YJ has an Altman-Z score of -5.76. This is a bad value and indicates that YJ is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.76, YJ is doing worse than 77.42% of the companies in the same industry.
There is no outstanding debt for YJ. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -5.76
ROIC/WACCN/A
WACC8.59%
YJ Yearly LT Debt VS Equity VS FCFYJ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

2.3 Liquidity

YJ has a Current Ratio of 1.97. This is a normal value and indicates that YJ is financially healthy and should not expect problems in meeting its short term obligations.
YJ has a Current ratio of 1.97. This is in the better half of the industry: YJ outperforms 70.97% of its industry peers.
YJ has a Quick Ratio of 1.86. This is a normal value and indicates that YJ is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of YJ (1.86) is better than 80.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.97
Quick Ratio 1.86
YJ Yearly Current Assets VS Current LiabilitesYJ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

0

3. Growth

3.1 Past

YJ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.91%, which is quite good.
YJ shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.70%.
YJ shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -48.62% yearly.
EPS 1Y (TTM)9.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-34.7%
Revenue growth 3Y-42.11%
Revenue growth 5Y-48.62%
Sales Q2Q%-34.96%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
YJ Yearly Revenue VS EstimatesYJ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B
YJ Yearly EPS VS EstimatesYJ Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 0 10 -10 20 30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for YJ. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
YJ Price Earnings VS Forward Price EarningsYJ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
YJ Per share dataYJ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

YJ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

YUNJI INC-ADR

NASDAQ:YJ (5/23/2025, 9:05:07 PM)

1.603

+0.01 (+0.82%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)04-11 2025-04-11
Earnings (Next)06-09 2025-06-09
Inst Owners0.67%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap31.52M
Analysts37.78
Price TargetN/A
Short Float %4.24%
Short Ratio0.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.54
P/FCF N/A
P/OCF N/A
P/B 0.21
P/tB 0.25
EV/EBITDA N/A
EPS(TTM)-0.98
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.26
FCFYN/A
OCF(TTM)-0.89
OCFYN/A
SpS2.96
BVpS7.62
TBVpS6.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.11%
ROE -11.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.1%
FCFM N/A
ROA(3y)-9%
ROA(5y)-5.42%
ROE(3y)-11.82%
ROE(5y)-7.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.45%
GM growth 5Y20.21%
F-Score2
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1484.62%
Cap/Sales 46.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.97
Quick Ratio 1.86
Altman-Z -5.76
F-Score2
WACC8.59%
ROIC/WACCN/A
Cap/Depr(3y)942.69%
Cap/Depr(5y)754.36%
Cap/Sales(3y)18.68%
Cap/Sales(5y)12.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-33.33%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.7%
Revenue growth 3Y-42.11%
Revenue growth 5Y-48.62%
Sales Q2Q%-34.96%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-68.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-59.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y32.98%
OCF growth 3YN/A
OCF growth 5YN/A